Korjuny (catumaxomab)
Malignant ascites (and potential other indications)
Key Facts
About Pharmanovia
Pharmanovia is a private, commercial-stage pharmaceutical company that has built a significant global presence by focusing on the life cycle management of established small molecule drugs. Its business model centers on acquiring or licensing mature pharmaceutical brands and then leveraging patient insights to repurpose, reformulate, or re-engineer them to address ongoing unmet needs, thereby extending their commercial viability. With a portfolio of over 25 brands, operations in 15+ offices, and a team of 320+ employees, the company positions itself as an agile and imaginative partner for innovator pharma companies seeking to maximize the potential of their mature assets. The recent appointment of a new CEO with extensive multinational pharma experience signals a phase of strategic growth and consolidation.
View full company profile